The last line of defense against Surgical Site Infections
SurgX antimicrobial gel is designed to reduce surgical site
and post-surgical infections by destroying planktonic and
biofilm-encased bacteria. The proprietary, non-toxic formulation
conforms to the post-operative wound to provide proven
broad spectrum and sustained effectiveness for up to 5 days
Destroy Infectious Agents within SurgX
Leveraging Next Science’s proprietary Xbio™ technology, the comprehensive formulation kills pathogens enveloped within the gel by creating a high osmolarity environment coupled with a surfactant to induce cell lysis. The unique mechanism of action has broad-spectrum antimicrobial efficacy against gram-positive and gram-negative bacteria, fungi, persister cells, and spores, and can show a 7 log colony reduction within 2 minutes.1,2
Protect and Defend against SSI
The sterile gel creates a protective superhydrophilic layer that prevents surface attachment of free-floating bacteria while the Xbio technology eliminates pathogens in the gel3. The gel formulation quickly conforms to the wound-bed on and around the surgical site and maintains a consistent barrier that can defend against recolonization for up to 72 hours.3
SurgX is non-toxic and is compatible with a broad range of dressings*. It provides a protective, moist environment that safely facilitates natural healing.
SurgX Mechanism of Action
View the technology and results in our webinar presented by Next Science CTO, Dr. Matthew Myntti
SurgX with Xbio Technology Provides Broad Spectrum Planktonic Efficacy within the Gel
Suspension Time Kill Testing (2 minutes)2
Provides up to 7 log planktonic efficacy within the gel
SurgX with Xbio Technology Prevents Bacterial Adhesion without Maceration Through the Formation of an Oxygen Permeable Superhydrophilic Surface3
SurgX v. Control: ~107 Bacterial Barrier Testing Results
The SurgX barrier offers a unique mechanism with sustained antimicrobial effects. Testing confirms bacteria are unable to migrate through or proliferate within the presents of SurgX3
Do not cover with alginate dressings. For External topical use only. Do not ingest. Must not be used in or near the eyes.
INDICATIONS FOR USE
SurgX™ is indicated for the management of post-surgical wounds, stage I-IV pressure ulcers, partial and full-thickness wounds, diabetic foot and leg ulcers, first and second-degree burns, and grafted and donor sites.
SurgX™ should not be used if there is a history of allergy to any of the ingredients.
Benzalkonium chloride 0.13%, polyethylene glycol 400, polyethylene glycol 3350, sodium citrate, citric acid, and water.
1. Laboratory testing on file
2. Laboratory testing on file
3. Laboratory testing on file